Business Description
Accelerate Diagnostics Inc
NAICS : 325413
SIC : 5047
ISIN : US00430H1023
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.39 | |||||
Equity-to-Asset | -0.84 | |||||
Debt-to-Equity | -1.57 | |||||
Debt-to-EBITDA | -0.88 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -35.48 | |||||
Beneish M-Score | -5.22 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -21.4 | |||||
3-Year EBITDA Growth Rate | 27.9 | |||||
3-Year EPS without NRI Growth Rate | 34.8 | |||||
3-Year FCF Growth Rate | 29 | |||||
3-Year Book Growth Rate | 50 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.57 | |||||
9-Day RSI | 65.11 | |||||
14-Day RSI | 57.77 | |||||
6-1 Month Momentum % | -83.66 | |||||
12-1 Month Momentum % | -88.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.5 | |||||
Quick Ratio | 1.29 | |||||
Cash Ratio | 0.98 | |||||
Days Inventory | 150.98 | |||||
Days Sales Outstanding | 73.64 | |||||
Days Payable | 164.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36.2 | |||||
Shareholder Yield % | 131.77 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 18.59 | |||||
Operating Margin % | -395.47 | |||||
Net Margin % | -485.31 | |||||
FCF Margin % | -302.52 | |||||
ROA % | -145.96 | |||||
ROIC % | -135.49 | |||||
ROC (Joel Greenblatt) % | -754.79 | |||||
ROCE % | -1704.83 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.27 | |||||
EV-to-EBIT | -0.98 | |||||
EV-to-EBITDA | -1.05 | |||||
EV-to-Revenue | 3.98 | |||||
EV-to-FCF | -1.32 | |||||
Price-to-Median-PS-Value | 0.01 | |||||
Earnings Yield (Greenblatt) % | -102.04 | |||||
FCF Yield % | -154.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Accelerate Diagnostics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 11.25 | ||
EPS (TTM) (€) | -4.109 | ||
Beta | -0.59 | ||
Volatility % | 74.68 | ||
14-Day RSI | 57.77 | ||
14-Day ATR (€) | 0.041356 | ||
20-Day SMA (€) | 0.82825 | ||
12-1 Month Momentum % | -88.81 | ||
52-Week Range (€) | 0.68 - 9.1 | ||
Shares Outstanding (Mil) | 22.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Accelerate Diagnostics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Accelerate Diagnostics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Accelerate Diagnostics Inc Frequently Asked Questions
What is Accelerate Diagnostics Inc(STU:1A80)'s stock price today?
When is next earnings date of Accelerate Diagnostics Inc(STU:1A80)?
Does Accelerate Diagnostics Inc(STU:1A80) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |